These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6102838)

  • 21. [Clinical experiences with acute beta blockade in acute myocardial infarction].
    Pedersen F; Bechsgaard P; Nielsen PB; Rasmussen SL
    Ugeskr Laeger; 1979 Nov; 141(45):3086-9. PubMed ID: 43002
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of propranolol on recovery of heart rate variability following acute myocardial infarction and relation to outcome in the Beta-Blocker Heart Attack Trial.
    Lampert R; Ickovics JR; Viscoli CJ; Horwitz RI; Lee FA
    Am J Cardiol; 2003 Jan; 91(2):137-42. PubMed ID: 12521623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Special article. The role of beta-adrenergic blockade in myocardial infarction.
    Jewitt DE; Singh BN
    Prog Cardiovasc Dis; 1974; 16(4):421-38. PubMed ID: 4153071
    [No Abstract]   [Full Text] [Related]  

  • 24. Chronic beta blockade therapy in patients after myocardial infarction.
    Pratt CM; Roberts R
    Am J Cardiol; 1983 Oct; 52(7):661-4. PubMed ID: 6137945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era.
    Huikuri HV; Tapanainen JM; Lindgren K; Raatikainen P; Mäkikallio TH; Juhani Airaksinen KE; Myerburg RJ
    J Am Coll Cardiol; 2003 Aug; 42(4):652-8. PubMed ID: 12932596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Editorial: The pharmacology and therapeutic use of beta-adrenergic receptor blocking drugs in cardiovascular disease.
    Harrison DC
    Drugs; 1974; 7(1):1-7. PubMed ID: 4152164
    [No Abstract]   [Full Text] [Related]  

  • 27. International beta-blocker review in acute and postmyocardial infarction.
    Hjalmarson A
    Am J Cardiol; 1988 Jan; 61(3):26B-29B. PubMed ID: 2893529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group.
    Second Chinese Cardiac Study (CCS-2) Collaborative Group
    J Cardiovasc Risk; 2000 Dec; 7(6):435-41. PubMed ID: 11189013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial.
    Chen ZM; Pan HC; Chen YP; Peto R; Collins R; Jiang LX; Xie JX; Liu LS;
    Lancet; 2005 Nov; 366(9497):1622-32. PubMed ID: 16271643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical experience with dextro-alprenolol.
    Vohra JK; Thompson PL; Sloman JG
    Br Med J; 1970 Mar; 1(5699):791-2. PubMed ID: 4392655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Modulation of the beta-adrenergic system during acute myocardial infarction: rationale for a new clinical trial].
    Ibáñez B; Fuster V; Macaya C; Jiménez-Borreguero J; Iñiguez A; Fernández-Ortiz A; Sanz G; Sánchez-Brunete V
    Rev Esp Cardiol; 2011 Jul; 64 Suppl 2():28-33. PubMed ID: 21807284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Renaissance of beta blocker therapy in myocardial infarct].
    Seidl K; Hauer B; Zahn R; Senges J
    Z Kardiol; 1996 Oct; 85(10):737-44. PubMed ID: 9036699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Forum: beta-adrenoreceptor blockade after acute myocardial infarction.
    Aust N Z J Med; 1982 Apr; 12(2):119-24. PubMed ID: 6124228
    [No Abstract]   [Full Text] [Related]  

  • 34. [Use of beta-adrenergic blocking agents in acute myocardial infarction (author's transl)].
    Wirtzfeld A; Klein G; Himmler FC; Schmidt G
    Herz; 1981 Apr; 6(2):73-83. PubMed ID: 6112196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spontaneous variability of ventricular arrhythmias in patients at increased risk for sudden death after acute myocardial infarction: consecutive ambulatory electrocardiographic recordings of 88 patients.
    Pratt CM; Théroux P; Slymen D; Riordan-Bennett A; Morisette D; Galloway A; Seals AA; Hallstrom A
    Am J Cardiol; 1987 Feb; 59(4):278-83. PubMed ID: 2880497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta-adrenergic blocking agents in prevention of sudden death.
    Chamberlain DA
    Adv Cardiol; 1978; 25():196-205. PubMed ID: 30260
    [No Abstract]   [Full Text] [Related]  

  • 37. Impact of clinical trials on the use of beta blockers after acute myocardial infarction and its relation to other risk indicators for death and 1-year mortality rate.
    Karlson BW; Herlitz J; Hjalmarson A
    Clin Cardiol; 1994 Jun; 17(6):311-6. PubMed ID: 7915221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta-blockers after myocardial infarction.
    Med Lett Drugs Ther; 1979 Dec; 21(25):101. PubMed ID: 44732
    [No Abstract]   [Full Text] [Related]  

  • 39. Combined receptor intervention and myocardial infarction.
    Chamberlain DA; Vincent R
    Drugs; 1984; 28 Suppl 2():88-108. PubMed ID: 6151893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hospitalization rates of generic metoprolol compared with the original beta-blocker in an epidemiological database study.
    Ahrens W; Hagemeier C; Mühlbauer B; Pigeot I; Püntmann I; Reineke A; Steinbach M; Timm J
    Pharmacoepidemiol Drug Saf; 2007 Dec; 16(12):1298-307. PubMed ID: 17957709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.